IBD: ROLE OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES
IBD:抗中性粒细胞胞浆抗体的作用
基本信息
- 批准号:2142700
- 负责人:
- 金额:$ 16.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-06-15 至 1995-05-31
- 项目状态:已结题
- 来源:
- 关键词:B lymphocyte Crohn's disease SDS polyacrylamide gel electrophoresis antibody formation antileukocyte isoantibody autoantibody biomarker diagnosis design /evaluation enzyme linked immunosorbent assay family gastrointestinal disorder diagnosis human subject immunofluorescence technique immunoglobulin isotypes immunoglobulin structure inflammatory bowel diseases neutrophil posttranslational modifications ulcerative colitis western blottings
项目摘要
The importance of establishing the diagnosis of ulcerative colitis arises
at two levels. Acute idiopathic ulcerative colitis of recent onset must be
distinguished from a variety of disorders that mimic it. Second,
ulcerative colitis must be distinguished from Crohn's disease. The
distinction between ulcerative colitis and Crohn's disease carries
important prognostic and therapeutic implications. Development of a
convenient and reliable blood test which could aid in diagnosing ulcerative
colitis and might parallel disease activity or predict and impending flare
would be an important advance. In other immunologically mediated
disorders, serum autoantibodies have been of major diagnostic use and have
provided insights into the underlying disease pathogenesis. In some cases,
autoantibodies have been used to reveal the molecular structure/function of
intracellular molecules. The study of autoantibodies at the molecular and
cellular level is now viewed as an important "bridge between the clinical
and basic sciences". We have recently found a subset of anti-neutrophil
cytoplasmic autoantibodies in the majority of patients with ulcerative
colitis. This UC-related ANCA is distinct from the ANCA which was
originally reported in patients with Wegener's granulomatosus, using the
ELISA assay described. The goal of this project is to assess the clinical
utility of ANCA as a disease marker for ulcerative colitis, establish the
identity and characteristics of the neutrophil cytoplasmic antigen(s) to
which ANCA is reactive, and to define the characteristics of the
immunoglobulins which comprise ANCA. In addition to facilitating the
development of a diagnostic marker of ulcerative colitis, these studies
will provide information which will be critical for subsequent
investigations of the immunologic mechanisms of production and regulation
of ANCA.
建立溃疡性结肠炎诊断的重要性
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(3)
Perinuclear anti-neutrophil cytoplasmic antibodies are spontaneously produced by mucosal B cells of ulcerative colitis patients.
- DOI:10.4049/jimmunol.155.6.3262
- 发表时间:1995-09
- 期刊:
- 影响因子:4.4
- 作者:S. Targan;C. Landers;L. Cobb;R. Macdermott;A. Vidrich
- 通讯作者:S. Targan;C. Landers;L. Cobb;R. Macdermott;A. Vidrich
Nuclear localization of the antigen detected by ulcerative colitis-associated perinuclear antineutrophil cytoplasmic antibodies.
通过溃疡性结肠炎相关核周抗中性粒细胞胞质抗体检测抗原的核定位。
- DOI:
- 发表时间:1995
- 期刊:
- 影响因子:0
- 作者:Billing,P;Tahir,S;Calfin,B;Gagne,G;Cobb,L;Targan,S;Vidrich,A
- 通讯作者:Vidrich,A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephan R. Targan其他文献
Serial 6-mercaptopurine (6-MP) metabolite measurements in combination with dose escalation unmasks an important biochemical explanation for "6-MP resistance"
- DOI:
10.1016/s0016-5085(00)85698-x - 发表时间:
2000-04-01 - 期刊:
- 影响因子:
- 作者:
Marla C. Dubinsky;Philip V. Hassard;Lori Y. Kam;Maria T. Abreu;Ernest G. Seidman;Stephan R. Targan;Eric A. Vasiliauskas - 通讯作者:
Eric A. Vasiliauskas
Thioguanine (6-TG): A therapeutic alternative in a subgroup of IBD patients failing 6-mercaptopurine (6-MP)
- DOI:
10.1016/s0016-5085(00)85701-7 - 发表时间:
2000-04-01 - 期刊:
- 影响因子:
- 作者:
Marla C. Dubinsky;Philip V. Hassard;Maria T. Abreu;Lori Y. Kam;Ernest G. Seidman;Stephan R. Targan;Eric A. Vasiliauskas - 通讯作者:
Eric A. Vasiliauskas
704 – Preoperative Serum Vedolizumab Levels Do Not Impact Postoperative Outcomes in Inflammatory Bowel Disease
- DOI:
10.1016/s0016-5085(19)37178-1 - 发表时间:
2019-05-01 - 期刊:
- 影响因子:
- 作者:
Aaron B. Parrish;Karen Zaghiyan;Nicole Lopez;Gil Melmed;Dermot McGovern;Anjali Jain;Carol Landers;Stephan R. Targan;Phillip Fleshner - 通讯作者:
Phillip Fleshner
369: NOVEL ASSOCIATIONS OF SARCOPENIA WITH CLINICAL, RADIOGRAPHIC, BLOOD PARAMETER, AND POLYGENIC RISK SCORE (PRS) MEASURES IN CROHN'S DISEASE (CD)
- DOI:
10.1016/s0016-5085(22)60195-1 - 发表时间:
2022-05-01 - 期刊:
- 影响因子:
- 作者:
Shishir Dube;Norman Gellada;Dalin Li;Talin Haritunians;Phillip Gu;Shaohong Yang;Gregory J. Botwin;Stephan R. Targan;Damini Dey;Yaniv Raphael;Cindy Kallman;Dermot P.B. Mcgovern - 通讯作者:
Dermot P.B. Mcgovern
Sa1879 - UBE2L3, ANCA, ASCA, and CBIR1 are Associated with Mechanisms of non-Response to Anti-TNF in IBD Patients with Adequate Drug Levels
- DOI:
10.1016/s0016-5085(17)31514-7 - 发表时间:
2017-04-01 - 期刊:
- 影响因子:
- 作者:
Leilei Zhu;Gil Melmed;Xiaofei Yan;Talin Haritunians;David Q. Shih;Eric Vasiliauskas;Andrew Ippoliti;Shervin Rabizadeh;Namita Singh;Stephan R. Targan;Zhenqiu Liu;Dalin Li;Dermot McGovern - 通讯作者:
Dermot McGovern
Stephan R. Targan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephan R. Targan', 18)}}的其他基金
Mechanisms of TL1A-driven Paneth Cell dysfunction in IBD
IBD 中 TL1A 驱动的潘氏细胞功能障碍的机制
- 批准号:
10077845 - 财政年份:2020
- 资助金额:
$ 16.76万 - 项目类别:
Mechanisms of TL1A-driven Paneth Cell dysfunction in IBD
IBD 中 TL1A 驱动的潘氏细胞功能障碍的机制
- 批准号:
10539302 - 财政年份:2020
- 资助金额:
$ 16.76万 - 项目类别:
Mechanisms of TL1A-driven Paneth Cell dysfunction in IBD
IBD 中 TL1A 驱动的潘氏细胞功能障碍的机制
- 批准号:
10311509 - 财政年份:2020
- 资助金额:
$ 16.76万 - 项目类别:
Molecular characterization of the role of RNASET2 in Severe Crohn's Disease
RNASET2 在严重克罗恩病中作用的分子表征
- 批准号:
10021036 - 财政年份:2019
- 资助金额:
$ 16.76万 - 项目类别:
Molecular characterization of the role of RNASET2 in Severe Crohn's Disease
RNASET2 在严重克罗恩病中作用的分子表征
- 批准号:
10226172 - 财政年份:2019
- 资助金额:
$ 16.76万 - 项目类别:
Role of TRIF-Dependent TLR Signaling in Intestinal Mucosa
TRIF 依赖性 TLR 信号转导在肠粘膜中的作用
- 批准号:
10225616 - 财政年份:2012
- 资助金额:
$ 16.76万 - 项目类别:
INFLAMMATORY BOWEL DISEASE CENTER: CLINICAL DATA REPOSITORY - TISSUE PROCUREMENT
炎症性肠病中心:临床数据存储库 - 组织采购
- 批准号:
8174459 - 财政年份:2009
- 资助金额:
$ 16.76万 - 项目类别:
IBD: Mucosa Specific Regulation of IFN-gamma Production
IBD:粘膜对 IFN-γ 产生的特异性调节
- 批准号:
7921223 - 财政年份:2009
- 资助金额:
$ 16.76万 - 项目类别:
INFLAMMATORY BOWEL DISEASE CENTER: CLINICAL DATA REPOSITORY - TISSUE PROCUREMENT
炎症性肠病中心:临床数据存储库 - 组织采购
- 批准号:
7952200 - 财政年份:2008
- 资助金额:
$ 16.76万 - 项目类别:
CORE--TISSUE PROCUREMENT & DATA ANALYSIS & SERUM ANALYSIS
核心——纸巾采购
- 批准号:
7487329 - 财政年份:2007
- 资助金额:
$ 16.76万 - 项目类别:
相似海外基金
Preclinical validation of small molecule immunomodulators for the treatment of Crohn's disease
小分子免疫调节剂治疗克罗恩病的临床前验证
- 批准号:
10600659 - 财政年份:2023
- 资助金额:
$ 16.76万 - 项目类别:
Application of social cognitive theory to physical activity behavior among adults with Crohn's disease
社会认知理论在克罗恩病成人体力活动行为中的应用
- 批准号:
10745823 - 财政年份:2023
- 资助金额:
$ 16.76万 - 项目类别:
Predicting Clinical Phenotypes in Crohn's Disease Using Machine Learning and Single-Cell 'omics
使用机器学习和单细胞组学预测克罗恩病的临床表型
- 批准号:
10586795 - 财政年份:2023
- 资助金额:
$ 16.76万 - 项目类别:
The Interplay of Host Genetic Variation and the Gut Microbiome in Crohn's Disease
克罗恩病宿主遗传变异与肠道微生物组的相互作用
- 批准号:
10751276 - 财政年份:2023
- 资助金额:
$ 16.76万 - 项目类别:
New insights into the development of metabolic dysfunction as a comorbidity in Crohn's disease.
关于代谢功能障碍作为克罗恩病合并症的发展的新见解。
- 批准号:
493720 - 财政年份:2023
- 资助金额:
$ 16.76万 - 项目类别:
Operating Grants
Fibrosis Associated Protein Inhibitor (FAPI) radiotracer-based imaging to identify fibrosis activity in intestinal Crohn's Disease (FATE-CD)
基于纤维化相关蛋白抑制剂 (FAPI) 的放射性示踪成像,可识别肠道克罗恩病 (FATE-CD) 中的纤维化活动
- 批准号:
MR/X030784/1 - 财政年份:2023
- 资助金额:
$ 16.76万 - 项目类别:
Research Grant
Sex Differences in Statural Growth Impairment in Pediatric Crohn's Disease: Part 2
儿童克罗恩病身高发育障碍的性别差异:第 2 部分
- 批准号:
10638422 - 财政年份:2023
- 资助金额:
$ 16.76万 - 项目类别:
Deconstructing the fibrotic microenvironment in Crohn's disease to promote tissue healing
解构克罗恩病的纤维化微环境,促进组织愈合
- 批准号:
MR/X008789/1 - 财政年份:2023
- 资助金额:
$ 16.76万 - 项目类别:
Research Grant
Significance of endoscopic quantitative evaluation of small bowel stricture in patients with Crohn's disease and elucidation of restenosis factors after balloon dilatation
内镜定量评估克罗恩病患者小肠狭窄的意义及阐明球囊扩张后再狭窄因素
- 批准号:
23K07446 - 财政年份:2023
- 资助金额:
$ 16.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Blood Protein Markers of Biologic Treatment Response in Crohn's Disease
克罗恩病生物治疗反应的血液蛋白标志物
- 批准号:
10666986 - 财政年份:2023
- 资助金额:
$ 16.76万 - 项目类别: